What’s IL-23 Got to Do With It? Targeted Therapies in the Management of IBD

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.


Resources

Faculty

Marla Dubinsky, MD

David P. Hudesman, MD, FACG, AGAF

Corey A. Siegel, MD, MS

Location and Time

Convention Center Room: Salon Ballroom H-J

Philadelphia Marriott, Philadelphia, PA

Monday, October 28, 2024 | 7:30–9:00 PM ET